Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
RGEN · NASDAQ · Biotechnology
Repligen (RGEN) · oqro.io/stocks/RGEN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$163.81−6.48 (−3.81%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a new position in RGEN for Q3 2026SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Viking Global disclosed a new position in RGEN for Q3 2026SourceInsider trade · Traded Oct 5, 2026 · Filed Oct 6, 2026
CEO sold ~$798K of RGEN shares in the open marketSourceInsider trade · Traded Oct 5, 2026 · Filed Oct 6, 2026
CEO sold ~$238K of RGEN shares in the open marketSourcePlanned sale · Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
Officer filed to sell about $798K of RGEN stockSourcePlanned sale · Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
Officer filed to sell about $238K of RGEN stockSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 26, 2026
CEO sold ~$1.6M of RGEN shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 26, 2026
CEO sold ~$863K of RGEN shares in the open marketSourceInsider trade · Traded Sep 21, 2026 · Filed Sep 23, 2026
CEO sold ~$977K of RGEN shares in the open marketSourceFederal contract · Signed Sep 1, 2026 · Updated Sep 15, 2026
Department of Agriculture awarded REPLIGEN CORP: $169K obligated to dateSourceInsider trade · Traded Aug 20, 2026 · Filed Aug 22, 2026
CEO sold ~$977K of RGEN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bradley Foster & Sargent Inc disclosed a new position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Duquesne Family Office disclosed a new position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Maverick Capital Ltd disclosed an increased position in RGEN for Q2 2026Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 29, 2026
Stephens Investment Management Group LLC disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Conestoga Capital Advisors, LLC disclosed a reduced position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 23, 2026
Artemis Investment Management LLP disclosed a reduced position in RGEN for Q2 2026SourceInsider trade · Traded Jul 16, 2026 · Filed Jul 18, 2026
CFO sold ~$80K of RGEN shares in the open marketInsider trade · Traded Jun 25, 2026 · Filed Jun 27, 2026
CFO sold ~$106K of RGEN shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed a reduced position in RGEN for Q1 2026SourceFederal contract · Signed May 28, 2026 · Updated May 28, 2026
Department of Health and Human Services awarded REPLIGEN CORP: $175K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 22, 2026
Segall Bryant & Hamill, LLC disclosed an increased position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Maverick Capital Ltd disclosed a new position in RGEN for Q1 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 30, 2026
Kornitzer Capital Management Inc disclosed a reduced position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 28, 2026
Stephens Investment Management Group LLC disclosed an increased position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 24, 2026
Conestoga Capital Advisors, LLC disclosed an increased position in RGEN for Q1 2026SourceInsider trade · Traded Apr 21, 2026 · Filed Apr 22, 2026
CEO sold ~$536K of RGEN shares in the open marketFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP disclosed a new position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
PointState Capital LP no longer reported RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Fred Alger Management, LLC disclosed an increased position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed an increased position in RGEN for Q4 2025Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 29, 2026
Impax Asset Management Group plc disclosed a reduced position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 9, 2026
Congress Asset Management Co disclosed an increased position in RGEN for Q4 2025SourceInsider trade · Traded Dec 17, 2025 · Filed Dec 19, 2025
Director sold ~$44K of RGEN shares in the open marketSourceInsider trade · Traded Nov 25, 2025 · Filed Nov 27, 2025
CEO sold ~$1.2M of RGEN shares in the open marketSourcePolitician trade (House) · Transaction Oct 30, 2025 · Disclosed Nov 21, 2025
Disclosed sale of RGEN — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Oct 31, 2025 · Disclosed Nov 21, 2025
Disclosed sale of RGEN — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Oct 30, 2025 · Disclosed Nov 21, 2025
Disclosed purchase of RGEN — reported range $1,001 - $15,000SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 28, 2025
Stephens Investment Management Group LLC disclosed an increased position in RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 24, 2025
Conestoga Capital Advisors, LLC disclosed a reduced position in RGEN for Q3 2025SourceInsider trade · Traded Sep 10, 2025 · Filed Sep 11, 2025
Director sold ~$1.79M of RGEN shares in the open marketSourceInsider trade · Traded Sep 10, 2025 · Filed Sep 11, 2025
Director sold ~$921K of RGEN shares in the open marketSourceInsider trade · Traded Sep 10, 2025 · Filed Sep 11, 2025
Director sold ~$390K of RGEN shares in the open marketSourceInsider trade · Traded Sep 10, 2025 · Filed Sep 11, 2025
Director sold ~$266K of RGEN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
W1M Asset Management Ltd disclosed a reduced position in RGEN for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed an increased position in RGEN for Q2 2025SourceInsider trade · Traded Sep 4, 2026 · Filed Sep 9, 2026
CEO sold ~$504K of RGEN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Holocene Advisors, LP disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Silvercrest Asset Management Group LLC disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Fred Alger Management, LLC disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
RTW Investments, LP disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
DF Dent & Co Inc disclosed a reduced position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a reduced position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
William Blair Investment Management, LLC disclosed a new position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Segall Bryant & Hamill, LLC disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Impax Asset Management Group plc disclosed a reduced position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 10, 2026
Wasatch Advisors LP disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 7, 2026
Congress Asset Management Co disclosed an increased position in RGEN for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates no longer reported RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
RTW Investments, LP disclosed an increased position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Fred Alger Management, LLC disclosed a reduced position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
DF Dent & Co Inc disclosed a reduced position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Holocene Advisors, LP disclosed a reduced position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Impax Asset Management Group plc disclosed an increased position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 21, 2026
Wasatch Advisors LP disclosed a new position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 14, 2026
Congress Asset Management Co disclosed an increased position in RGEN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 13, 2026
Artemis Investment Management LLP disclosed an increased position in RGEN for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
DF Dent & Co Inc disclosed a reduced position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Holocene Advisors, LP disclosed a reduced position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a reduced position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Segall Bryant & Hamill, LLC disclosed an increased position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 5, 2026
Stephens Investment Management Group LLC disclosed an increased position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 2, 2026
Conestoga Capital Advisors, LLC disclosed an increased position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 2, 2026
Artemis Investment Management LLP disclosed an increased position in RGEN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 2, 2026
Kornitzer Capital Management Inc disclosed an increased position in RGEN for Q4 2025SourceInsider trade · Traded Nov 18, 2025 · Filed Nov 20, 2025
Officer sold ~$331K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$896K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$466K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$448K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$386K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$320K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$307K of RGEN shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 15, 2025
Director sold ~$269K of RGEN shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
PointState Capital LP disclosed a new position in RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Perceptive Advisors LLC disclosed an increased position in RGEN for Q3 2025SourceInsider trade · Traded Nov 12, 2025 · Filed Nov 14, 2025
Director sold ~$1.75M of RGEN shares in the open marketSourceInsider trade · Traded Nov 12, 2025 · Filed Nov 14, 2025
Director sold ~$777K of RGEN shares in the open marketSourceInsider trade · Traded Nov 12, 2025 · Filed Nov 14, 2025
Director sold ~$739K of RGEN shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Holocene Advisors, LP disclosed an increased position in RGEN for Q3 2025SourceInsider trade · Traded Nov 12, 2025 · Filed Nov 14, 2025
Director sold ~$580K of RGEN shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
DF Dent & Co Inc disclosed a reduced position in RGEN for Q3 2025SourceInsider trade · Traded Nov 12, 2025 · Filed Nov 14, 2025
Director sold ~$74K of RGEN shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Bridgewater Associates disclosed a new position in RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Sands Capital Management, LLC no longer reported RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Artemis Investment Management LLP disclosed an increased position in RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
W1M Asset Management Ltd no longer reported RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
Segall Bryant & Hamill, LLC disclosed a reduced position in RGEN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 6, 2025
Impax Asset Management Group plc disclosed a reduced position in RGEN for Q3 2025SourceInsider trade · Traded Sep 10, 2025 · Filed Sep 11, 2025
Director sold ~$131K of RGEN shares in the open marketSourceInsider trade · Traded Sep 10, 2025 · Filed Sep 11, 2025
Director sold ~$11K of RGEN shares in the open marketSource